Nomura Holdings’s Nektar Therapeutics NKTR Stock Holding History

Nomura Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.79M	Buy	+40,000	New	+$2.93M	﹤0.01%	991

Other funds holding NKTR

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Nomura Holdings's NKTR Position: Q2 2026 in Review

Nomura Holdings opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 38,657 shares worth $2.7M. The stake represents ﹤0.01% of the portfolio and ranks #1007 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in NKTR as recently as Q1 2022.

Nomura Holdings first reported a position in NKTR in Q2 2013 and has held it in 9 quarters since. 219 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

Nomura Holdings held 38,657 shares of Nektar Therapeutics worth $2.7M as of Q2 2026.
Nektar Therapeutics was a new Nomura Holdings position in Q2 2026.
Nektar Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1007 holding.
Nomura Holdings first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 9 quarters since.
219 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.